SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001214659-19-005756
Filing Date
2019-09-09
Accepted
2019-09-09 20:41:39
Documents
1
Period of Report
2019-08-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-45721.html 3  
1 PRIMARY DOCUMENT marketforms-45721.xml 3 2690
  Complete submission text file 0001214659-19-005756.txt   4200
Mailing Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301
Business Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301 (720) 505-4755
Brickell Biotech, Inc. (Issuer) CIK: 0000819050 (see all company filings)

IRS No.: 930948554 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O MIRAGEN THERAPEUTICS, INC. 6200 LOOKOUT ROAD, #100 BOULDER CO 80301
Business Address
Levy Adam Scott (Reporting) CIK: 0001693134 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-21088 | Film No.: 191084144